These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 20167290)

  • 1. Mortality and safety of catheter ablation for antiarrhythmic drug-refractory ventricular tachycardia in elderly patients with coronary artery disease.
    Inada K; Roberts-Thomson KC; Seiler J; Steven D; Tedrow UB; Koplan BA; Stevenson WG
    Heart Rhythm; 2010 Jun; 7(6):740-4. PubMed ID: 20167290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.
    AbdelWahab A; Sapp J
    Curr Cardiol Rep; 2017 Sep; 19(11):105. PubMed ID: 28900864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and mid-term outcome of catheter ablation of ventricular tachycardia in octogenarians.
    Frontera A; Panniker S; Breitenstein A; Bruno VD; Connolly GM; Wilson D; Rio T; Dhinoja MB; Hussain W; Schilling RJ; Thomas G; Wong T; Hunter RJ; Sacher F; Jaïs P; Duncan E
    Europace; 2017 Aug; 19(8):1369-1377. PubMed ID: 27974359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catheter ablation for ventricular tachycardia in patients with an implantable cardioverter defibrillator (CALYPSO) pilot trial.
    Al-Khatib SM; Daubert JP; Anstrom KJ; Daoud EG; Gonzalez M; Saba S; Jackson KP; Reece T; Gu J; Pokorney SD; Granger CB; Hess PL; Mark DB; Stevenson WG
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):151-7. PubMed ID: 25332150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catheter ablation and antiarrhythmic drugs for haemodynamically tolerated post-infarction ventricular tachycardia; long-term outcome in relation to acute electrophysiological findings.
    Della Bella P; De Ponti R; Uriarte JA; Tondo C; Klersy C; Carbucicchio C; Storti C; Riva S; Longobardi M
    Eur Heart J; 2002 Mar; 23(5):414-24. PubMed ID: 11846499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Baseline Antiarrhythmic Drug on Outcomes With Ablation in Ischemic Ventricular Tachycardia: A VANISH Substudy (Ventricular Tachycardia Ablation Versus Escalated Antiarrhythmic Drug Therapy in Ischemic Heart Disease).
    Parkash R; Nault I; Rivard L; Gula L; Essebag V; Nery P; Tung S; Raymond JM; Sterns L; Doucette S; Wells G; Tang ASL; Stevenson WG; Sapp JL
    Circ Arrhythm Electrophysiol; 2018 Jan; 11(1):e005663. PubMed ID: 29305400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the multicenter thermocool ventricular tachycardia ablation trial.
    Stevenson WG; Wilber DJ; Natale A; Jackman WM; Marchlinski FE; Talbert T; Gonzalez MD; Worley SJ; Daoud EG; Hwang C; Schuger C; Bump TE; Jazayeri M; Tomassoni GF; Kopelman HA; Soejima K; Nakagawa H;
    Circulation; 2008 Dec; 118(25):2773-82. PubMed ID: 19064682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes after repeat ablation of ventricular tachycardia in structural heart disease: An analysis from the International VT Ablation Center Collaborative Group.
    Tzou WS; Tung R; Frankel DS; Di Biase L; Santangeli P; Vaseghi M; Bunch TJ; Weiss JP; Tholakanahalli VN; Lakkireddy D; Vunnam R; Dickfeld T; Mathuria N; Tedrow U; Vergara P; Vakil K; Nakahara S; Burkhardt JD; Stevenson WG; Callans DJ; Della Bella P; Natale A; Shivkumar K; Marchlinski FE; Sauer WH
    Heart Rhythm; 2017 Jul; 14(7):991-997. PubMed ID: 28506710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute hemodynamic decompensation during catheter ablation of scar-related ventricular tachycardia: incidence, predictors, and impact on mortality.
    Santangeli P; Muser D; Zado ES; Magnani S; Khetpal S; Hutchinson MD; Supple G; Frankel DS; Garcia FC; Bala R; Riley MP; Lin D; Rame JE; Schaller R; Dixit S; Marchlinski FE; Callans DJ
    Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):68-75. PubMed ID: 25491601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study.
    Giorgberidze I; Saksena S; Krol RB; Munsif AN; Kolettis T; Mathew P; Varanasi S; Prakash A; Delfaut P; Lewis CB
    Am J Cardiol; 1997 Sep; 80(5B):3F-9F. PubMed ID: 9291444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia.
    Arenal Á; Ávila P; Jiménez-Candil J; Tercedor L; Calvo D; Arribas F; Fernández-Portales J; Merino JL; Hernández-Madrid A; Fernández-Avilés FJ; Berruezo A
    J Am Coll Cardiol; 2022 Apr; 79(15):1441-1453. PubMed ID: 35422240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Outcome With Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
    Santangeli P; Zado ES; Supple GE; Haqqani HM; Garcia FC; Tschabrunn CM; Callans DJ; Lin D; Dixit S; Hutchinson MD; Riley MP; Marchlinski FE
    Circ Arrhythm Electrophysiol; 2015 Dec; 8(6):1413-21. PubMed ID: 26546346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial human feasibility of infusion needle catheter ablation for refractory ventricular tachycardia.
    Sapp JL; Beeckler C; Pike R; Parkash R; Gray CJ; Zeppenfeld K; Kuriachan V; Stevenson WG
    Circulation; 2013 Nov; 128(21):2289-95. PubMed ID: 24036605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of repeat procedures for catheter ablation of postinfarction ventricular tachycardia.
    Kosmidou I; Inada K; Seiler J; Koplan B; Stevenson WG; Tedrow UB
    Heart Rhythm; 2011 Oct; 8(10):1516-22. PubMed ID: 21703217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and predictors of mortality following ablation of ventricular tachycardia in patients with an implantable cardioverter-defibrillator.
    Sauer WH; Zado E; Gerstenfeld EP; Marchlinski FE; Callans DJ
    Heart Rhythm; 2010 Jan; 7(1):9-14. PubMed ID: 19939743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of radiofrequency catheter ablation of ventricular tachycardia in cardiac sarcoidosis: report from a multicenter registry.
    Jefic D; Joel B; Good E; Morady F; Rosman H; Knight B; Bogun F
    Heart Rhythm; 2009 Feb; 6(2):189-95. PubMed ID: 19187909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventricular Tachycardia and ICD Therapy Burden With Catheter Ablation Versus Escalated Antiarrhythmic Drug Therapy.
    Samuel M; Healey JS; Nault I; Sterns LD; Essebag V; Gray C; Hruczkowski T; Gardner M; Parkash R; Sapp JL
    JACC Clin Electrophysiol; 2023 Jun; 9(6):808-821. PubMed ID: 37380314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlates and prognosis of early recurrence after catheter ablation for ventricular tachycardia due to structural heart disease.
    Nagashima K; Choi EK; Tedrow UB; Koplan BA; Michaud GF; John RM; Epstein LM; Tokuda M; Inada K; Kumar S; Lin KY; Barbhaiya CR; Chinitz JS; Enriquez AD; Helmbold AF; Stevenson WG
    Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):883-8. PubMed ID: 25136076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Success of Irrigated Radiofrequency Catheter Ablation of Sustained Ventricular Tachycardia: Post-Approval THERMOCOOL VT Trial.
    Marchlinski FE; Haffajee CI; Beshai JF; Dickfeld TL; Gonzalez MD; Hsia HH; Schuger CD; Beckman KJ; Bogun FM; Pollak SJ; Bhandari AK
    J Am Coll Cardiol; 2016 Feb; 67(6):674-683. PubMed ID: 26868693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.